The primary endpoint, median OS was 6.5 months for patients with sorafenib and 4.2 months for patients with placebo (Llovet et al., 2008)
Key support mechanisms include: Production linked incentive (PLI) schemes for manufacturing of pharma Bulk drug parks with shared infrastructure Financial support schemes for small and medium enterprises Streamlined regulatory approval processes The initiatives resulted in operational cost reductions which enhanced the global market competitiveness of Indian pharmaceutical companies
All of these overlapping factors, caused by GLP-1s and their side effects, can make it a little difficult to say whether the fatigue which patients can feel is directly due to the medication or perhaps just an effect of the changes the body is undergoing as it adapts to this change in food intake and metabolism
Second, different GH cutoff levels for GHD were selected: 5 ng/mL 5,6 , 6 ng/mL 9 , 7 ng/mL 1 , 8 ng/mL 3,8 , and 10 ng/mL 4,14
409,410 This holds promise for developing novel therapeutic strategies targeting the gut microbiota to manage DPN effectively